Recent studies have shown that human epidermal growth factor receptor-2 (HER2) expression is elevated in approximately 18–25% of breast cancers [32], and GRP94 is required for both the proper intracellular trafficking and stability of HER2 protein [33]. Here, ERBB2 is linked to breast carcinoma.